| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/11/2004 | WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/11/2004 | WO2003009809A3 Cancer treatment with gö6976 and its related compounds |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2003002060A3 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 03/11/2004 | WO2003000191A3 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049799 Method for screening agents capable of treating obesity |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040048922 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative |
| 03/11/2004 | US20040048917 New use of compounds as antibacterial agents |
| 03/11/2004 | US20040048900 Nicotine and/or nicotine agonists for the treatment of general anesthetic effects and side effects |
| 03/11/2004 | US20040048896 Treating gastric acid disorders by orally administering a proton pump inhibitor and a mixture of buffers |
| 03/11/2004 | US20040048890 E.g., montelukast sodium and pseudoephedrine; treatment of allergic rhinitis or asthma |
| 03/11/2004 | US20040048887 Respiratory disorders, particularly inhalants for asthma or COPD |
| 03/11/2004 | US20040048869 Dopamine D4 receptor antagonist with antidepressant or anxiolytic agent. |
| 03/11/2004 | US20040048846 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 03/11/2004 | US20040048841 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 03/11/2004 | US20040048840 Modulation of matrix metalloproteinase (MMP) activity with aldosterone blocker(s) |
| 03/11/2004 | US20040048830 Administering a cyclic oligosaccharide such as 6-per-deoxy-6-per-(2,3- dihydroxypropylthio)- gamma -cyclodextrin; treating depression and other psychological disorders such as Cushing's syndrome, schizophrenia and severe anxiety |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048812 Health supplement |
| 03/11/2004 | US20040048805 Antilipemic agents |
| 03/11/2004 | US20040048803 Treatment of thrombosis by administering a CD154 inhibitor, especially a metalloproteinase inhibitor. |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048783 Acidic insulin preparations having improved stability |
| 03/11/2004 | US20040048777 Compounds and compositions for delivering active agents |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048316 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048286 Can be used to diagnose and/or treat cardiovascular conditions including cardiac hypertrophy, myocardial infarction, stroke, arteriosclerosis, and heart failure |
| 03/11/2004 | US20040048280 A polynucleotide that includes an endothelial specific enhancer element |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040047921 Useful for restoring or maintaining colon functionality in a human; prophylaxis of cancer |
| 03/11/2004 | US20040047918 Napthalamide compositions and uses thereof |
| 03/11/2004 | US20040047917 Drug delivery and targeting with vitamin B12 conjugates |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/11/2004 | US20040047903 For use in therapy of cancer |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047890 Containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; treating subject with a substance which inhibits an immune-system costimulation |
| 03/11/2004 | US20040047885 Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047870 For therapy of atherosclerosis, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, stenosis, restenosis and/or in-stent-stenosis |
| 03/11/2004 | US20040047869 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047835 Combinations of drug conjugates with other therapeutic agents, including chemotherapy drugs. The invention also provides methods of using the combinations for the treatment of diseases associated with cell proliferation such as tumors |
| 03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
| 03/11/2004 | DE10239161A1 Stimulating gastric function without causing undesirable side-effects, using nutritional supplement containing vitamin C and magnesium |
| 03/11/2004 | DE10219784A1 Orally administered solution used for rehydration, especially in diarrhea patients, is enclosed in taste masking carrier of absorbable polymer, specifically in form of microcapsules |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | CA2497048A1 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496904A1 Genetic suppression and replacement |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496550A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | CA2495330A1 Estrogen replacement regimen |
| 03/11/2004 | CA2495144A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/11/2004 | CA2492645A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/10/2004 | EP1396489A1 Heteroaromatic bicyclic derivatives useful as anticancer agents |
| 03/10/2004 | EP1396273A1 Bicyclo(2.2.1.)heptanes and related compounds |
| 03/10/2004 | EP1396270A1 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 03/10/2004 | EP1396269A1 Boronic acid salts of multivalent metals used in the preparation of a medicament for treating thrombosis |
| 03/10/2004 | EP1396267A2 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/10/2004 | EP1396265A1 Ion exchange resins for alleviation of upper gastrointestinal irritation |
| 03/10/2004 | EP1396261A1 Skincare composition containing caffeine |
| 03/10/2004 | EP1396255A1 Method for suppressing reduction of elasticity of skin |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395289A1 Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
| 03/10/2004 | EP1395288A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 03/10/2004 | EP1395287A1 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases |
| 03/10/2004 | EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395274A2 Compositions and methods for inhibiting metastasis |
| 03/10/2004 | EP1395273A1 Targeted delivery of drugs for the treatment of viral infections |
| 03/10/2004 | EP1395264A2 Targeted delivery of drugs for the treatment of parasitic infections |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |